Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

current


Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003

  • Published Date:

    August 8, 2003

  • Source:
    MMWR. Morbidity and mortality weekly report. 2003; 52(31):735-9.
  • Language:
    English
Filetype[PDF-260.70 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like: